Qube Research & Technologies LTD Vera Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 13,376 shares of VERA stock, worth $646,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,376Holding current value
$646,194% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$208 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$190 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$161 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$143 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$135 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.31B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...